Table 2

Histology-specific miRNA deregulation patterns
LEIO LIPOm FIBRO SYN
hsa-miR-128b
hsa-miR-100
hsa-miR-99a hsa-miR-17-3p¹ hsa-miR-107¹ - Activated
hsa-miR-212 hsa-miR-128a miRNAs
hsa-miR-199b
hsa-miR-98¹
hsa-miR-217¹
hsa-miR-181a
hsa-miR-330
hsa-miR-30a-3p hsa-miR-29c
hsa-miR-374 hsa-miR-302a* hsa-miR-154* hsa-miR-221 Silenced miRNAs
hsa-miR-361 hsa-miR-130 hsa-miR-21¹ hsa-miR-217¹
hsa-miR-208 hsa-miR-424
hsa-miR-25
hsa-miR-126*
hsa-miR-31
hsa-miR-302a
hsa-miR-26a¹
OSTEOSARCOMA SPECIFIC miRNAs
hsa-miR-122a hsa-miR-7 g
hsa-miR-18 hsa-miR-147
hsa-miR-34c hsa-miR-210 Activated mIRNAs
hsa-miR-375 hsa-miR-187
hsa-miR-204 hsa-miR-134
hsa-miR-138 hsa-miR-211

Boldface denotes activated or silenced miRNAs compared to mesenchymal normal tissue only. Boldface italicized text denotes activated or silenced miRNAs compared to both mesenchymal normal tissue and all normal tissue. A superscript 1 denotes miRNAs which are also differentially activated in epithelial cancers.

Fountzilas et al.

Fountzilas et al. BMC Genomics 2012 13:332   doi:10.1186/1471-2164-13-332

Open Data